Concordia Pharmaceuticals Inc., Barbados
1 clinical trials · Sponsor
◉ Watch Concordia Pharmaceuticals Inc., Barbados
| Record | Firm | Date |
|---|---|---|
| Efficacy & Safety of KAPVAY™ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder (NCT01439126) | Concordia Pharmaceuticals Inc., Barbados | 2011-08-01 |
Track Concordia Pharmaceuticals Inc., Barbados automatically
Every clearance here is in the API, with alerts when new ones post.